Back to Search
NADIA HANNA, M.D.
M.D.
Family Medicine Physician
NPI: 1043226822IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Additional
Education
OTHER
Class of 1995
Research & Publications (20)
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.
PMID 19096313·J Thorac Oncol·2009
3-trial
Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era.
PMID 19327421·Am J Cardiol·2009
4-observational
Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery.
PMID 19114277·Am J Obstet Gynecol·2009
7-preclinical
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
PMID 19366998·J Med Genet·2009
8-other
Ex vivo analyses of ano-genital wart lymphocytes to study the human papillomavirus immune response.
PMID 19479132·Acta Derm Venereol·2009
8-other
Is midtrimester short cervix a sign of intraamniotic inflammation?
PMID 19318146·Am J Obstet Gynecol·2009
8-other
SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
PMID 19438935·Clin Genet·2009
5-case
The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.
PMID 19532011·Curr Opin Oncol·2009
6-review
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.
PMID 19221167·Oncologist·2009
3-trial
Second-line treatment of advanced non-small cell lung cancer.
PMID 18379366·J Thorac Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3333 CLARK RD, SUITE 190
SARASOTA, FL 34231 - Phone
- (941) 922-1400
Quick Facts
- NPI
- 1043226822
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile